Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of tissue factor in venous thrombosis.

Literature DB >> 20690821

Role of tissue factor in venous thrombosis.

David A Manly¹, Jeremiah Boles, Nigel Mackman.

Abstract

Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide. However, the mechanisms by which clots are formed in the deep veins have not been determined. Tissue factor (TF) is the primary initiator of the coagulation cascade and is essential for hemostasis. Under pathological conditions, TF is released into the circulation on small-membrane vesicles termed microparticles (MPs). Recent studies suggest that elevated levels of MP TF may trigger thrombosis. This review provides an overview of the role of TF in VTE.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Biomarkers
Thromboplastin

Year: 2011 PMID： 20690821 PMCID： PMC3076951 DOI： 10.1146/annurev-physiol-042210-121137

Source DB: PubMed Journal: Annu Rev Physiol ISSN： 0066-4278 Impact factor: 19.318

87 in total

1. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

Authors: R A Fleck; L V Rao; S I Rapaport; N Varki
Journal: Thromb Res Date: 1990-07-15 Impact factor: 3.944

2. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

Authors: F A Anderson; H B Wheeler; R J Goldberg; D W Hosmer; N A Patwardhan; B Jovanovic; A Forcier; J E Dalen
Journal: Arch Intern Med Date: 1991-05

3. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors: T A Drake; J H Morrissey; T S Edgington
Journal: Am J Pathol Date: 1989-05 Impact factor: 4.307

4. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor.

Authors: Y Komiyama; A H Pedersen; W Kisiel
Journal: Biochemistry Date: 1990-10-09 Impact factor: 3.162

5. DVT: a new era in anticoagulant therapy.

Authors: Nigel Mackman; Richard C Becker
Journal: Arterioscler Thromb Vasc Biol Date: 2010-02-05 Impact factor: 8.311

Review 6. Rivaroxaban: a new oral factor Xa inhibitor.

Authors: Elisabeth Perzborn; Susanne Roehrig; Alexander Straub; Dagmar Kubitza; Wolfgang Mueck; Volker Laux
Journal: Arterioscler Thromb Vasc Biol Date: 2010-02-05 Impact factor: 8.311

7. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.

Authors: T A Drake; J Cheng; A Chang; F B Taylor
Journal: Am J Pathol Date: 1993-05 Impact factor: 4.307

8. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide.

Authors: N Mackman; M S Sawdey; M R Keeton; D J Loskutoff
Journal: Am J Pathol Date: 1993-07 Impact factor: 4.307

Review 9. Pathogenesis of venous thrombosis.

Authors: E F Mammen
Journal: Chest Date: 1992-12 Impact factor: 9.410

Review 10. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.

Authors: G P Clagett; J S Reisch
Journal: Ann Surg Date: 1988-08 Impact factor: 12.969

42 in total

Review 1. At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.

Authors: Peter C Grayson; Mariana J Kaplan
Journal: J Leukoc Biol Date: 2015-10-02 Impact factor: 4.962

2. A computational model based on fibrin accumulation for the prediction of stasis thrombosis following flow-diverting treatment in cerebral aneurysms.

Authors: Chubin Ou; Wei Huang; Matthew Ming-Fai Yuen
Journal: Med Biol Eng Comput Date: 2016-04-22 Impact factor: 2.602

Review 3. Microparticles in hemostasis and thrombosis.

Authors: A Phillip Owens; Nigel Mackman
Journal: Circ Res Date: 2011-05-13 Impact factor: 17.367

4. Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.

Authors: Andrea T Obi; Elizabeth Andraska; Yogendra Kanthi; Chase W Kessinger; Megan Elfline; Cathy Luke; Teruna J Siahaan; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal: Thromb Haemost Date: 2016-12-15 Impact factor: 5.249

5. Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of stroke.

Authors: Shaobin Wang; Brandi Reeves; Erica M Sparkenbaugh; Janice Russell; Zbigniew Soltys; Hua Zhang; James E Faber; Nigel S Key; Daniel Kirchhofer; D Neil Granger; Nigel Mackman; Rafal Pawlinski
Journal: JCI Insight Date: 2016-07-21

6. A Mathematical Model of Venous Thrombosis Initiation.

Authors: Priscilla Elizondo; Aaron L Fogelson
Journal: Biophys J Date: 2016-12-20 Impact factor: 4.033

Review 7. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.

Authors: Olivier Morel; Nicolas Morel; Laurence Jesel; Jean-Marie Freyssinet; Florence Toti
Journal: Semin Immunopathol Date: 2011-08-25 Impact factor: 9.623

8. Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39.

Authors: Anuli C Anyanwu; Yogendra Kanthi; Keigo Fukase; Hui Liao; Tekashi Mimura; Karl C Desch; Martin Gruca; Saabir Kaskar; Hussein Sheikh-Aden; Liguo Chi; Raymond Zhao; Vinita Yadav; Thomas W Wakefield; Matthew C Hyman; David J Pinsky
Journal: Arterioscler Thromb Vasc Biol Date: 2019-04 Impact factor: 8.311

Review 9. Bench to bedside: new developments in our understanding of the pathophysiology of thrombosis.

Authors: Nigel S Key
Journal: J Thromb Thrombolysis Date: 2013-04 Impact factor: 2.300

Review 10. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.

Authors: Julia E Geddings; Nigel Mackman
Journal: Blood Date: 2013-06-24 Impact factor: 22.113